Individual weekly doses can cost hundreds of dollars
Clinical Trial Evidence for Wegovy Wegovy approval was supported by large, randomized clinical trials, including the STEP 1 study: 1,961 adults with obesity or overweight plus weight-related health conditions 68-week study duration Average weight loss of approximately 14.9% of body weight 86% of participants lost at least 5% of body weight 69% lost at least 10% 50% lost at least 15% Participants followed reduced-calorie diets and increased physical activity Before receiving FDA approval, GLP-1 medications completed Phase I, Phase II, and Phase III trials
Pricing can change due to stock, product updates, supplier costs, and site updates
Given the recent results of the CREDENCE trial, many patients will also be treated with an SGLT2-inhibitor, allowing the trial to study the combined use of these agents on renal outcomes
Management: fiber supplements, adequate water intake, magnesium supplementation
Learn more about peptide therapy and discover whether BPC-157 injections are right for you by calling (602) 595-7836 or scheduling a consultation with Revive Wellness and Rejuvenation today